Replies to post #368811 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

jonjones325

Now comes 2-73 with an extraordinary amount of detail and safety. Hard to dismiss if it proves to be better.

This is why and how it works. This is why it’s better and this is how we lead the way to understanding CNS diseases. And we’ve shown our platforms effectiveness across diseases and populations.

It’s be amazingly messed up for the FDA to dismiss it and make us to another trial. But I guess we shouldn’t underestimate the power of big pharmas influence.

Excellent...insightful post...THX.

[Rubyred77]

Luckily Missling has trials overseas for such a scenario. No better thing than an upset population wondering why a REAL new therapy for Alzheimer’s suffers are approved in xyz country but not here in good ol U S of A.